HEMOSTATIC FACTORS AND PREVALENT CORONARY HEART-DISEASE - THE FINRISK HEMOSTASIS STUDY

被引:40
作者
SALOMAA, V
RASI, V
PEKKANEN, J
VAHTERA, E
JAUHIAINEN, M
VARTIAINEN, E
MYLLYLA, G
EHNHOLM, C
机构
[1] NATL PUBL HLTH INST, DEPT ENVIRONM EPIDEMIOL, SF-00280 HELSINKI 28, FINLAND
[2] NATL PUBL HLTH INST, DEPT BIOCHEM, SF-00280 HELSINKI 28, FINLAND
[3] FINNISH RED CROSS & BLOOD TRANSFUS SERV, DEPT HAEMOSTASIS, HELSINKI, FINLAND
关键词
HEMOSTASIS; CORONARY HEART DISEASE; FIBRINOGEN; FACTOR-VII; PLASMINOGEN; LIPOPROTEIN (A); COAGULATION;
D O I
10.1093/oxfordjournals.eurheartj.a060387
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the association of haemostatic factors with prevalent coronary heart disease (CHD) in the population-based FINRISK Haemostasis Study. Of the 2365 participants ages 45-64 years, 88 men and 44 women with prevalent CHD were identified. The participants with CHD were older and had lower high density lipoprotein cholesterol, higher triglycerides and higher body mass index than the participants without CHD. Men with CHD had significantly higher plasma fibrinogen (P < 0.0001, adjusted for age and smoking) and lipoprotein (a) (Lp (a), P = 0.001, adjusted for age) concentrations than those without CHD. Among women, the findings were consistent with those of men, but only fibrinogen reached the conventional level of statistical significance (P=0.04). No difference was observed in factor VII antigen, factor VII activity or in plasminogen. The association of Lp (a) with prevalent CHD was dependent on fibrinogen concentration (P=0.02 for the interaction-term) and on non-HDL cholesterol concentration (P=0.01 for the interaction-term). These cross-sectional results do not prove causality, but they demonstrate a considerable accumulation of prevalent CHD among persons with high Lp (a), fibrinogen and non-HDL chelesterol.
引用
收藏
页码:1293 / 1299
页数:7
相关论文
共 44 条
  • [1] RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY
    ALFTHAN, G
    PEKKANEN, J
    JAUHIAINEN, M
    PITKANIEMI, J
    KARVONEN, M
    TUOMILEHTO, J
    SALONEN, JT
    EHNHOLM, C
    [J]. ATHEROSCLEROSIS, 1994, 106 (01) : 9 - 19
  • [2] THE ASSOCIATION BETWEEN SERUM LP(A) CONCENTRATIONS AND ANGIOGRAPHICALLY ASSESSED CORONARY ATHEROSCLEROSIS - DEPENDENCE ON SERUM LDL LEVELS
    ARMSTRONG, VW
    CREMER, P
    EBERLE, E
    MANKE, A
    SCHULZE, F
    WIELAND, H
    KREUZER, H
    SEIDEL, D
    [J]. ATHEROSCLEROSIS, 1986, 62 (03) : 249 - 257
  • [3] BAINTON D, 1992, BRIT HEART J, V68, P60
  • [4] BAKER IA, 1982, BRIT HEART J, V47, P490, DOI 10.1136/hrt.47.5.490
  • [5] BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261
  • [6] LIPOPROTEIN(A) IN THE ARTERIAL-WALL
    BEISIEGEL, U
    NIENDORF, A
    WOLF, K
    REBLIN, T
    RATH, M
    [J]. EUROPEAN HEART JOURNAL, 1990, 11 : 174 - 183
  • [7] BERGLUND U, 1988, THROMB HAEMOSTASIS, V60, P21
  • [8] FIBRINOGEN, FACTOR-VII CLOTTING ACTIVITY AND CORONARY-ARTERY DISEASE SEVERITY
    BROADHURST, P
    KELLEHER, C
    HUGHES, L
    IMESON, JD
    RAFTERY, EB
    [J]. ATHEROSCLEROSIS, 1990, 85 (2-3) : 169 - 173
  • [9] HEMATOLOGICAL PROGNOSTIC INDEXES AFTER MYOCARDIAL-INFARCTION - EVIDENCE FROM THE DIET AND REINFARCTION TRIAL (DART)
    BURR, ML
    HOLLIDAY, RM
    FEHILY, AM
    WHITEHEAD, PJ
    [J]. EUROPEAN HEART JOURNAL, 1992, 13 (02) : 166 - 170
  • [10] Chambless L E, 1992, Ann Epidemiol, V2, P723